At a glance
- Originator Kotobuki Seiyaku
- Class Antihypertensives; Small molecules; Vasodilators
- Mechanism of Action Phosphoric diester hydrolase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 26 May 2001 Discontinued-Preclinical for Hypertension in Japan (Unknown route)
- 26 May 2001 Discontinued-Preclinical for Hypertension in USA (Unknown route)
- 01 Aug 1997 Suspended-Preclinical for Hypertension in Japan (Unknown route)